ABC | Volume 114, Nº2, February 2020

Update Update of the Brazilian Guideline on Nuclear Cardiology – 2020 Arq Bras Cardiol. 2020; 114(2):325-429 273. Redwood SR, Ferrari R, Marber MS. Myocardial hibernation and stunning: from physiological principles to clinical practice. Heart. 1998;80(3):218-22. 274. Bito V van der Velden J, Claus P, Dommke C, Van Lommel A, Mortelmans L, et al. Reduced force generating capacity in myocytes from chronically ischemic, hibernating myocardium. Circ Res. 2007;100(2):229-37. 275. Shabana A, El-Menyar A. Myocardial viability: What we knew and what is new. Cardiol Res Pract. 2012; 2012:607486. 276. Kaandorp TA, LambHJ, van derWall EE, de Roos A, Bax JJ. Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction. Heart. 2005;91:1359-65. 277. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30(6):1451-60. 278. Dilszian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection but viablemyocardiumby the reinjection of thalliumafter stress: redistribution imaging. N Engl J Med. 1990;323(3):141-6. 279. Levine MG, McGill CC, Ahlberg AW, White MP, Giri S, Shareef B, et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol. 1999;83(1):1-5. 280. Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols and tracers. J Nucl Cardiol. 2016;23(3):640-2. 281. YangMF, Keng F, He ZX. Nitrate-augmentedmyocardial perfusion imaging for assessment of myocardial viability: recent advances. Nucl Med Commun. 2009;30(6):415-9. 282. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187-226. 283. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler R, et al. ASNC imaging guidelines for nuclear cardiology procedures PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol. 2009 Jun; 16:651. 284. Hedgire SS, Osborne M, Verdini DJ, Ghoshhajra BB. Updates on stress imagingtestingandmyocardialviabilitywithadvanced imagingmodalities. Curr Treat Options Cardiovasc Med. 2017;19(4):26. 285. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, FreemanM, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007; 50:2002-12. 286. DiCarliMF,HachamovitchR,BermanDS.Theartandscienceofpredicting postrevascularization improvement in left ventricular (LV) function in patients with severely depressed LV function. JACC. 2002;40(10):1744-7. 287. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151-8. 288. BonowRO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, et al; STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular diysfunction. N Engl J Med. 2011;364(17):1617-25. 289. Patel H, Mazur W, Williams KA Sr, Kalra DK. Myocardial viability-State of the art: Is it still relevant and how to best assess it with imaging? Trends Cardiovasc Med. 2018;28(1):24-37. 290. Bhat A, Gan GC, Tan TC, Hsu C, Denniss AR. Myocardial Viability: From Proof of Concept to Clinical Practice. Cardiol Res Pract. 2016; 2016:1020818. 291. Gewirtz H, Dilsizian V. Myocardial Viability: Survival mechanisms and molecular imaging targets in acute and chronic ischemia. Circ Res. 2017;120(7):1197-212 292. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–ExecutiveSummary.AReportoftheAmericanCollegeofCardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/ ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J AmColl Cardiol. 2003;42(7):1318-33. 293. Slomka PJ, Nishina H, Berman DS, Kang X, Friedman JD, Hayes SW, et al. Automatic quantification of myocardial perfusion stress-rest change: a newmeasure of ischemia. J Nucl Med. 2004;45(2):183-91. 294. Bocher M, Blevis IM, Tsukerman L, Shrem Y, Kovalski G, Volokh L. A fast cardiac gamma camera with dynamic SPECT capabilities: Design, system validation and future potential. Eur J Nucl Med Mol Imaging. 2010;37(10):1887-902. 295. Buechel RR, Herzog BA, Husmann L, Burger IA, Pazhenkottil AP, Treyer V, et al. Ultrafast nuclear myocardial perfusion imaging on a new gamma camera with semiconductor detector technique: first clinical validation. Eur J Nucl Med Mol Imaging. 2010;37(4):773-8. Errata em: Eur J Nucl Med Mol Imaging. 2011;38(6):1172. 296. GarciaEV,FaberTL,EstevesFP.CardiacdedicatedultrafastSPECTcameras: New designs and clinical implications. J Nucl Med. 2011;52(2):210-7. 297. Duvall WL, Croft LB, Godiwala T, Ginsberg E, George T, Henzlova MJ. Reduced isotope dose with rapid SPECT MPI imaging: initial experience with a CZT camera. J Nucl Cardiol. 2010;17(6):1009-14. 298. Gimelli A, Bottai M, Genovesi D, Giorgetti A, Di Martino F, Marzullo P. High diagnostic accuracy of low-dose gated-SPECT with solid-state ultrafast detectors: preliminary clinical results. Eur J Nucl Med Mol Imaging. 2012;39(1):83-90. 299. Hindorf C, Oddstig J, Hedeer F, HanssonMJ, Jögi J, EngblomH. Importance of correct patient positioning in myocardial perfusion SPECT when using a CZT camera. J Nucl Cardiol 2014;21(4):695-702. 300. Oldan JD, Shaw LK, Hofmann P, Phelan M, Nelson J, Pagnanelli R, et al. Prognostic value of the cadmium-zinc-telluride camera: A comparison with a conventional (anger) camera. J Nucl Cardiol. 2015;23(6):1280-7 301. Lima R, Peclat T, Soares T, Ferreira C, Souza AC, Camargo G. Comparison of the prognostic value of myocardial perfusion imaging using a CZT-SPECT camera with a conventional anger camera. J Nucl Cardiol.2016;24(1):245-51. 302. Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol. 2009;16(2):255-76. 303. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13(4):601-9. 304. DePuey E, Gadiraju R, Clark J, Thompson L, Anstett F, Shwartz S. Ordered subset expectation maximization and wide beam reconstruction (WBR) ‘‘half-time’’ gated myocardial perfusion SPECT functional imaging: A comparison to ‘‘full-time’’ filtered back projection. J Nucl Cardiol. 2008;15(4):547-63. 305. Lima R, DeLorenzo A, Camargo G, Oliveira G, Reis T, Peclat T, et al. Prognostic value of myocardium perfusion imaging with a new reconstruction algorithm. J Nucl Cardiol. 2014;21(1):149-57. 306. Falcão A, Chalela W, Giorgi MC, Imada R, Soares Jr J, Do Val R, et al. Myocardial blood flow assessment with 82rubidium-PET imaging in patients with left bundle branch block. Clinics. 2015;70(11):726-32. 307. Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54(2):150–6. 308. Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission 421